Potential drug discovery for COVID-19 treatment targeting Cathepsin L using a deep learning-based strategy
Cathepsin L (CTSL), a cysteine protease that can cleave and activate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, could be a promising therapeutic target for coronavirus disease 2019 (COVID-19). However, there is still no clinically available CTSL inhibitor that ca...
Main Authors: | Wei-Li Yang, Qi Li, Jing Sun, Sia Huat Tan, Yan-Hong Tang, Miao-Miao Zhao, Yu-Yang Li, Xi Cao, Jin-Cun Zhao, Jin-Kui Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037022001799 |
Similar Items
-
Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia
by: Jingzhe Song, et al.
Published: (2023-10-01) -
Cathepsin B, D and S as Potential Biomarkers of Brain Glioma Malignancy
by: Lukasz Oldak, et al.
Published: (2022-11-01) -
Serum and Synovial Levels of Cathepsin G and Cathepsin K in Patients with Psoriatic Arthritis and Their Correlation with Disease Activity Indices
by: Stanislava Dimitrova Popova-Belova, et al.
Published: (2023-10-01) -
All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma
by: Hester van Mourik, et al.
Published: (2022-09-01) -
Impact of Enniatin B and Beauvericin on Lysosomal Cathepsin B Secretion and Apoptosis Induction
by: Mohammed Aufy, et al.
Published: (2023-01-01)